healthcare News
Vanda misses Q4 revenue but raises guidance on Bysantic opportunity
Fanapt sales climb 24% in 2025; key regulatory decision expected February 21
Neurocrine tops revenue estimates on INGREZZA strength
Biotech company forecasts 7-11% growth for flagship drug amid analyst concerns over competition
Royalty Pharma surges after beating earnings, hikes dividend 7%
Biotech royalty firm posted $874M in Q4 Portfolio Receipts, repurchased $1.2B of shares
Veru doubles cash position, secures FDA pathway for obesity drug
Operating loss narrows 47% as biotech prepares Phase 2b PLATEAU trial with tirzepatide combination
Tenet Healthcare surges on 40% EPS beat, $1.9B CommonSpirit deal
Hospital operator beats Q4 estimates and regains full ownership of Conifer Health Solutions in transformative transaction
Humana plunges 4.3% on widening losses, Medicare ratings collapse
Health insurer faces $1-3bn hit to quality bonus payments as medical costs soar and Star Ratings tumble
iBio posts wider loss on zero revenue, secures $26M PIPE financing
Frazier Life Sciences-led funding extends cash runway to Q3 2028 as biotech advances obesity treatment pipeline
Personalis surges 9.8% on Medicare coverage for lung cancer test
Coverage decision expands access to NeXT Personal MRD test for 230,000 annual US patients